| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | modulation of chemical synaptic transmission | JAK2 USP8 STXBP1 PTPRD MYO6 STXBP5L SYNE1 ICA1 DNM1L UNC13C GRIK5 PLCL1 ALG13 | 3.50e-06 | 663 | 86 | 13 | GO:0050804 |
| GeneOntologyBiologicalProcess | regulation of trans-synaptic signaling | JAK2 USP8 STXBP1 PTPRD MYO6 STXBP5L SYNE1 ICA1 DNM1L UNC13C GRIK5 PLCL1 ALG13 | 3.56e-06 | 664 | 86 | 13 | GO:0099177 |
| GeneOntologyBiologicalProcess | anterograde trans-synaptic signaling | JAK2 USP8 STXBP1 PTPRD CLCN3 MYO6 STXBP5L SYNE1 ICA1 DNM1L UNC13C GRIK5 PLCL1 SLC1A2 ALG13 | 6.36e-06 | 931 | 86 | 15 | GO:0098916 |
| GeneOntologyBiologicalProcess | chemical synaptic transmission | JAK2 USP8 STXBP1 PTPRD CLCN3 MYO6 STXBP5L SYNE1 ICA1 DNM1L UNC13C GRIK5 PLCL1 SLC1A2 ALG13 | 6.36e-06 | 931 | 86 | 15 | GO:0007268 |
| GeneOntologyBiologicalProcess | trans-synaptic signaling | JAK2 USP8 STXBP1 PTPRD CLCN3 MYO6 STXBP5L SYNE1 ICA1 DNM1L UNC13C GRIK5 PLCL1 SLC1A2 ALG13 | 7.05e-06 | 939 | 86 | 15 | GO:0099537 |
| GeneOntologyBiologicalProcess | vesicle-mediated transport in synapse | 7.70e-06 | 321 | 86 | 9 | GO:0099003 | |
| GeneOntologyBiologicalProcess | synaptic signaling | JAK2 USP8 STXBP1 PTPRD CLCN3 MYO6 STXBP5L SYNE1 ICA1 DNM1L UNC13C GRIK5 PLCL1 SLC1A2 ALG13 | 1.12e-05 | 976 | 86 | 15 | GO:0099536 |
| GeneOntologyBiologicalProcess | neurotransmitter transport | 1.05e-04 | 259 | 86 | 7 | GO:0006836 | |
| GeneOntologyBiologicalProcess | synaptic vesicle cycle | 1.18e-04 | 264 | 86 | 7 | GO:0099504 | |
| GeneOntologyBiologicalProcess | signal release from synapse | 1.66e-04 | 195 | 86 | 6 | GO:0099643 | |
| GeneOntologyBiologicalProcess | neurotransmitter secretion | 1.66e-04 | 195 | 86 | 6 | GO:0007269 | |
| GeneOntologyBiologicalProcess | synaptic vesicle exocytosis | 1.77e-04 | 125 | 86 | 5 | GO:0016079 | |
| GeneOntologyBiologicalProcess | synaptic vesicle maturation | 2.36e-04 | 29 | 86 | 3 | GO:0016188 | |
| GeneOntologyCellularComponent | extrinsic component of plasma membrane | 2.17e-05 | 137 | 86 | 6 | GO:0019897 | |
| GeneOntologyCellularComponent | extrinsic component of membrane | 4.58e-05 | 230 | 86 | 7 | GO:0019898 | |
| GeneOntologyCellularComponent | presynaptic endocytic zone | 5.25e-05 | 18 | 86 | 3 | GO:0098833 | |
| GeneOntologyCellularComponent | glutamatergic synapse | JAK2 USP8 STXBP1 PTPRD CLCN3 MYO6 SPTAN1 RTN3 GRIK5 ARHGAP39 PDE10A SLC1A2 | 1.26e-04 | 817 | 86 | 12 | GO:0098978 |
| GeneOntologyCellularComponent | presynaptic membrane | 1.46e-04 | 277 | 86 | 7 | GO:0042734 | |
| GeneOntologyCellularComponent | presynapse | STXBP1 PTPRD CLCN3 SEPTIN4 MYO6 ICA1 RTN3 DNM1L UNC13C GRIK5 SLC1A2 PICALM | 2.66e-04 | 886 | 86 | 12 | GO:0098793 |
| GeneOntologyCellularComponent | secretory vesicle | USP8 STXBP1 CLCN3 SEPTIN4 STXBP5L SPTAN1 ICA1 PKP1 DNM1L UNC13C ICA1L PICALM FERMT3 COL1A1 | 5.34e-04 | 1246 | 86 | 14 | GO:0099503 |
| GeneOntologyCellularComponent | synaptic membrane | 6.55e-04 | 583 | 86 | 9 | GO:0097060 | |
| GeneOntologyCellularComponent | parallel fiber to Purkinje cell synapse | 7.37e-04 | 43 | 86 | 3 | GO:0098688 | |
| GeneOntologyCellularComponent | postsynapse | JAK2 USP8 STXBP1 CLCN3 MYO6 SYNE1 SPTAN1 RTN3 GRIK5 ARHGAP39 SLC1A2 PICALM | 9.16e-04 | 1018 | 86 | 12 | GO:0098794 |
| GeneOntologyCellularComponent | presynaptic endocytic zone membrane | 1.47e-03 | 14 | 86 | 2 | GO:0098835 | |
| GeneOntologyCellularComponent | synaptic vesicle | 1.49e-03 | 300 | 86 | 6 | GO:0008021 | |
| GeneOntologyCellularComponent | extrinsic component of cytoplasmic side of plasma membrane | 1.59e-03 | 56 | 86 | 3 | GO:0031234 | |
| GeneOntologyCellularComponent | exocytic vesicle | 2.07e-03 | 320 | 86 | 6 | GO:0070382 | |
| Domain | ICA69 | 2.10e-05 | 2 | 86 | 2 | PF04629 | |
| Domain | Islet_autoAg_Ica1_C | 2.10e-05 | 2 | 86 | 2 | IPR006723 | |
| Domain | ICA69 | 2.10e-05 | 2 | 86 | 2 | SM01237 | |
| Domain | Islet_autoAg_Ica1/Ica1-like | 2.10e-05 | 2 | 86 | 2 | IPR024114 | |
| Domain | AH_dom | 2.08e-04 | 5 | 86 | 2 | IPR010504 | |
| Domain | Arfaptin | 2.08e-04 | 5 | 86 | 2 | PF06456 | |
| Domain | Arfaptin | 2.08e-04 | 5 | 86 | 2 | SM01015 | |
| Domain | AH | 2.08e-04 | 5 | 86 | 2 | PS50870 | |
| Domain | Spectrin_repeat | 3.16e-04 | 29 | 86 | 3 | IPR002017 | |
| Domain | Spectrin/alpha-actinin | 4.25e-04 | 32 | 86 | 3 | IPR018159 | |
| Domain | SPEC | 4.25e-04 | 32 | 86 | 3 | SM00150 | |
| Pubmed | MDN1 PTPRD NACC1 SYNE1 SPTAN1 DOCK7 DNM1L GRIK5 PLCL1 ARHGAP39 SLC1A2 DDB1 PICALM FERMT3 | 1.58e-07 | 963 | 89 | 14 | 28671696 | |
| Pubmed | Diverse functions of myosin VI elucidated by an isoform-specific α-helix domain. | 2.83e-07 | 22 | 89 | 4 | 26950368 | |
| Pubmed | 6.48e-06 | 2 | 89 | 2 | 27018747 | ||
| Pubmed | Subcellular localization of ATBF1 regulates MUC5AC transcription in gastric cancer. | 6.48e-06 | 2 | 89 | 2 | 17330845 | |
| Pubmed | Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling. | 8.17e-06 | 281 | 89 | 7 | 28706196 | |
| Pubmed | 8.95e-06 | 187 | 89 | 6 | 26460568 | ||
| Pubmed | 1.94e-05 | 3 | 89 | 2 | 30143522 | ||
| Pubmed | CCR7-mediated physiological lymphocyte homing involves activation of a tyrosine kinase pathway. | 1.94e-05 | 3 | 89 | 2 | 12393730 | |
| Pubmed | 1.94e-05 | 3 | 89 | 2 | 32059807 | ||
| Pubmed | 1.94e-05 | 3 | 89 | 2 | 35596061 | ||
| Pubmed | 1.94e-05 | 3 | 89 | 2 | 19615795 | ||
| Pubmed | ICA1L forms BAR-domain complexes with PICK1 and is crucial for acrosome formation in spermiogenesis. | 1.94e-05 | 3 | 89 | 2 | 26306493 | |
| Pubmed | 1.94e-05 | 3 | 89 | 2 | 31679624 | ||
| Pubmed | 1.94e-05 | 3 | 89 | 2 | 25405202 | ||
| Pubmed | USP8 RBM11 STXBP1 PTPRD MYO6 HIPK1 SYNE1 SPTAN1 ASB3 GAS7 ANKRD36 EIF3D RECK | 2.33e-05 | 1285 | 89 | 13 | 35914814 | |
| Pubmed | 2.41e-05 | 65 | 89 | 4 | 34431227 | ||
| Pubmed | 3.17e-05 | 347 | 89 | 7 | 17114649 | ||
| Pubmed | 3.87e-05 | 4 | 89 | 2 | 32017846 | ||
| Pubmed | 3.87e-05 | 4 | 89 | 2 | 36139418 | ||
| Pubmed | 3.87e-05 | 4 | 89 | 2 | 19596800 | ||
| Pubmed | 4.69e-05 | 251 | 89 | 6 | 27507650 | ||
| Pubmed | 6.44e-05 | 5 | 89 | 2 | 21695558 | ||
| Pubmed | 6.44e-05 | 5 | 89 | 2 | 15659226 | ||
| Pubmed | 6.44e-05 | 5 | 89 | 2 | 18771702 | ||
| Pubmed | 6.44e-05 | 5 | 89 | 2 | 26258302 | ||
| Pubmed | 6.44e-05 | 5 | 89 | 2 | 23479728 | ||
| Pubmed | Role of the clathrin adaptor PICALM in normal hematopoiesis and polycythemia vera pathophysiology. | 6.44e-05 | 5 | 89 | 2 | 25552701 | |
| Pubmed | STXBP1 SEPTIN4 MYO6 SYNE1 SPTAN1 NCKIPSD DOCK7 RTN3 DNM1L PLCL1 ARHGAP39 SLC1A2 DDB1 | 7.03e-05 | 1431 | 89 | 13 | 37142655 | |
| Pubmed | 7.84e-05 | 170 | 89 | 5 | 36470425 | ||
| Pubmed | HIV-1 Vpr triggers mitochondrial destruction by impairing Mfn2-mediated ER-mitochondria interaction. | 9.65e-05 | 6 | 89 | 2 | 22438978 | |
| Pubmed | Development and transdifferentiation into inner hair cells require Tbx2. | 9.65e-05 | 6 | 89 | 2 | 36687561 | |
| Pubmed | Common variants in FOXP1 are associated with generalized vitiligo. | 9.65e-05 | 6 | 89 | 2 | 20526340 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | JAK2 MYO6 STXBP5L RTN3 ZFHX3 ANKMY1 ARHGAP39 PDE10A TEP1 SLC4A5 ICA1L SLC25A37 RECK | 1.05e-04 | 1489 | 89 | 13 | 28611215 |
| Pubmed | MDN1 CLCN3 SETD6 SPTAN1 PEX3 GAS7 DNM1L HABP2 PLCL1 PLK4 RYR1 ALG13 | 1.12e-04 | 1293 | 89 | 12 | 15342556 | |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | 1.14e-04 | 736 | 89 | 9 | 29676528 | |
| Pubmed | Helios is a key transcriptional regulator of outer hair cell maturation. | 1.35e-04 | 7 | 89 | 2 | 30464345 | |
| Pubmed | The IAP-antagonist ARTS initiates caspase activation upstream of cytochrome C and SMAC/Diablo. | 1.35e-04 | 7 | 89 | 2 | 21869827 | |
| Pubmed | 1.35e-04 | 101 | 89 | 4 | 18519826 | ||
| Pubmed | Huntingtin interacting proteins are genetic modifiers of neurodegeneration. | 1.56e-04 | 197 | 89 | 5 | 17500595 | |
| Pubmed | 1.61e-04 | 41 | 89 | 3 | 19786618 | ||
| Pubmed | Network organization of the huntingtin proteomic interactome in mammalian brain. | 1.96e-04 | 621 | 89 | 8 | 22794259 | |
| Pubmed | 1.98e-04 | 622 | 89 | 8 | 14574404 | ||
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | 2.26e-04 | 807 | 89 | 9 | 30575818 | |
| Pubmed | 2.30e-04 | 214 | 89 | 5 | 22199357 | ||
| Pubmed | 2.30e-04 | 9 | 89 | 2 | 10571082 | ||
| Pubmed | 2.35e-04 | 638 | 89 | 8 | 31182584 | ||
| Pubmed | 2.46e-04 | 118 | 89 | 4 | 30979931 | ||
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | MDN1 MYO6 SYNE1 SPTAN1 DOCK7 PKP1 RTN3 BIRC3 DNM1L EIF3D MED23 DDB1 | 2.75e-04 | 1425 | 89 | 12 | 30948266 |
| Pubmed | The septin CDCrel-1 is dispensable for normal development and neurotransmitter release. | 2.88e-04 | 10 | 89 | 2 | 11739749 | |
| Pubmed | 3.36e-04 | 128 | 89 | 4 | 23858473 | ||
| Pubmed | 3.46e-04 | 129 | 89 | 4 | 23022380 | ||
| Pubmed | PEX14 is required for microtubule-based peroxisome motility in human cells. | 3.66e-04 | 54 | 89 | 3 | 21525035 | |
| Pubmed | 3.66e-04 | 131 | 89 | 4 | 28634551 | ||
| Pubmed | Epistatic genetic interactions between Insm1 and Ikzf2 during cochlear outer hair cell development. | 4.20e-04 | 12 | 89 | 2 | 37171961 | |
| Pubmed | Cooperative polarization of MCAM/CD146 and ERM family proteins in melanoma. | 4.25e-04 | 377 | 89 | 6 | 38117590 | |
| Pubmed | 4.96e-04 | 13 | 89 | 2 | 36754021 | ||
| Pubmed | Loss of flow responsive Tie1 results in Impaired Aortic valve remodeling. | 5.78e-04 | 14 | 89 | 2 | 31319059 | |
| Pubmed | 6.03e-04 | 403 | 89 | 6 | 30562941 | ||
| Pubmed | 6.65e-04 | 15 | 89 | 2 | 20526338 | ||
| Pubmed | 7.59e-04 | 16 | 89 | 2 | 25300579 | ||
| Pubmed | 8.08e-04 | 1168 | 89 | 10 | 19946888 | ||
| Pubmed | 8.33e-04 | 163 | 89 | 4 | 16512683 | ||
| Pubmed | 8.50e-04 | 72 | 89 | 3 | 36376293 | ||
| Pubmed | 8.59e-04 | 17 | 89 | 2 | 20963938 | ||
| Pubmed | 8.59e-04 | 17 | 89 | 2 | 33226740 | ||
| Pubmed | RUNX1 Familial Platelet Disorder with Associated Myeloid Malignancies | 8.59e-04 | 17 | 89 | 2 | 33661592 | |
| Pubmed | 8.59e-04 | 17 | 89 | 2 | 12036298 | ||
| Pubmed | 8.59e-04 | 17 | 89 | 2 | 19861958 | ||
| Pubmed | DDX41-Associated Familial Myelodysplastic Syndrome and Acute Myeloid Leukemia | 9.65e-04 | 18 | 89 | 2 | 34723452 | |
| Pubmed | Why do cellular proteins linked to K63-polyubiquitin chains not associate with proteasomes? | 9.74e-04 | 170 | 89 | 4 | 23314748 | |
| Pubmed | Human variation in alcohol response is influenced by variation in neuronal signaling genes. | 9.95e-04 | 171 | 89 | 4 | 20201926 | |
| Pubmed | 1.02e-03 | 446 | 89 | 6 | 24255178 | ||
| Pubmed | LRF maintains genome integrity by regulating the non-homologous end joining pathway of DNA repair. | 1.11e-03 | 79 | 89 | 3 | 26446488 | |
| Pubmed | 1.25e-03 | 182 | 89 | 4 | 15102471 | ||
| Pubmed | Proteomic analysis of a detergent-resistant membrane skeleton from neutrophil plasma membranes. | 1.32e-03 | 21 | 89 | 2 | 12202484 | |
| Pubmed | Hedgehog signaling controls mesenchymal growth in the developing mammalian digestive tract. | 1.45e-03 | 22 | 89 | 2 | 20430747 | |
| Pubmed | 1.50e-03 | 191 | 89 | 4 | 33762435 | ||
| Pubmed | 1.58e-03 | 486 | 89 | 6 | 20936779 | ||
| Pubmed | The small GTPase Rac1 regulates auditory hair cell morphogenesis. | 1.58e-03 | 23 | 89 | 2 | 20016102 | |
| Pubmed | An expanded Oct4 interaction network: implications for stem cell biology, development, and disease. | 1.67e-03 | 91 | 89 | 3 | 20362542 | |
| Pubmed | 1.72e-03 | 24 | 89 | 2 | 22534482 | ||
| Pubmed | 1.87e-03 | 25 | 89 | 2 | 12358155 | ||
| Pubmed | Human Sos1: a guanine nucleotide exchange factor for Ras that binds to GRB2. | 1.87e-03 | 25 | 89 | 2 | 8493579 | |
| Pubmed | 1.90e-03 | 204 | 89 | 4 | 25659154 | ||
| Pubmed | Redundant functions of RIM1alpha and RIM2alpha in Ca(2+)-triggered neurotransmitter release. | 2.02e-03 | 26 | 89 | 2 | 17124501 | |
| Pubmed | Voltage-dependent conformational changes of Kv1.3 channels activate cell proliferation. | 2.04e-03 | 208 | 89 | 4 | 33230847 | |
| Pubmed | 2.07e-03 | 98 | 89 | 3 | 26561776 | ||
| Pubmed | Quantitative analysis of PPT1 interactome in human neuroblastoma cells. | 2.11e-03 | 210 | 89 | 4 | 26217791 | |
| Pubmed | 2.18e-03 | 27 | 89 | 2 | 11156964 | ||
| Pubmed | 2.25e-03 | 101 | 89 | 3 | 10997877 | ||
| Pubmed | 2.32e-03 | 102 | 89 | 3 | 11214970 | ||
| Pubmed | Activity-based chemical proteomics accelerates inhibitor development for deubiquitylating enzymes. | 2.34e-03 | 28 | 89 | 2 | 22118674 | |
| Pubmed | A functional reference map of the RNF8 interactome in cancer. | 2.42e-03 | 218 | 89 | 4 | 35831895 | |
| Pubmed | 2.45e-03 | 104 | 89 | 3 | 9205841 | ||
| Pubmed | Biochemical Reduction of the Topology of the Diverse WDR76 Protein Interactome. | 2.46e-03 | 219 | 89 | 4 | 31353912 | |
| Pubmed | 2.51e-03 | 29 | 89 | 2 | 14563677 | ||
| Pubmed | 2.51e-03 | 29 | 89 | 2 | 37160119 | ||
| GeneFamily | Classical BAR domain containing | 3.41e-04 | 8 | 64 | 2 | 1292 | |
| Coexpression | GSE40273_GATA1_KO_VS_WT_TREG_DN | 4.38e-06 | 200 | 86 | 7 | M9133 | |
| Coexpression | ZAK_PBMC_MRKAD5_HIV_1_GAG_POL_NEF_AGE_20_50YO_1DY_DN | ANKRD36B IKZF2 MDN1 CD7 TRAT1 SYNE1 CLK4 SPTAN1 CCR7 PLCL1 EIF3D GNG7 RECK | 2.50e-05 | 1012 | 86 | 13 | M40864 |
| Coexpression | VILIMAS_NOTCH1_TARGETS_UP | 2.59e-05 | 52 | 86 | 4 | MM1249 | |
| Coexpression | VILIMAS_NOTCH1_TARGETS_UP | 2.59e-05 | 52 | 86 | 4 | M1869 | |
| Coexpression | GSE11864_CSF1_VS_CSF1_PAM3CYS_IN_MAC_UP | 4.77e-05 | 197 | 86 | 6 | M3136 | |
| Coexpression | GSE17301_IFNA2_VS_IFNA2_AND_ACD3_ACD28_STIM_CD8_TCELL_DN | 5.04e-05 | 199 | 86 | 6 | M8044 | |
| ToppCell | mild_COVID-19_(asymptomatic)-CD4+_T_naive|World / disease group, cell group and cell class (v2) | 2.99e-08 | 157 | 89 | 7 | 23879e65a6acc33d9aad096cd23604a77b0ac9c2 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.36e-07 | 196 | 89 | 7 | 676c56b44ac29f7baecb62f49bb8597cc74c0a88 | |
| ToppCell | AT2_cells-IPF_03|World / lung cells shred on cell class, cell subclass, sample id | 1.41e-07 | 197 | 89 | 7 | 5e0d222872a25bb9e9069d3dffda2844bb69874a | |
| ToppCell | Neuronal|World / cells hierarchy compared to all cells using T-Statistic | 1.56e-07 | 200 | 89 | 7 | 48d801219bc771d6c7e151dc88ca4c179988de85 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD4+_T-Treg-Treg_3|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.45e-07 | 153 | 89 | 6 | 7480522a47e367f8facc4f5d599fbaf0b5ad4007 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD4+_T-Treg-Treg_3|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 7.23e-07 | 156 | 89 | 6 | 53ded973358e3e48054130131e959f0d1f4ef60f | |
| ToppCell | mild_COVID-19_(asymptomatic)-CD4+_T_naive|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2) | 1.08e-06 | 167 | 89 | 6 | 78d264af390bd89942ffbb2991dc94f50756d4c9 | |
| ToppCell | 15-Distal-Immune-Hematopoietic,_T_Cells|Distal / Age, Tissue, Lineage and Cell class | 1.95e-06 | 185 | 89 | 6 | 481e3d3b63f2e5b4783088523c3cf70a461aed27 | |
| ToppCell | PCW_10-12-Hematologic_Myeloid-Hem_Myeloid_macrophage|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.21e-06 | 189 | 89 | 6 | 440c422369de1c49112d18cf8c506a2a3a81f6ba | |
| ToppCell | Fetal_29-31_weeks-Immune-T_lymphocyte-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.28e-06 | 190 | 89 | 6 | 2a8de1cf27a9ebc3825cf9e7a489ecd064dfc7f9 | |
| ToppCell | PCW_10-12-Hematologic_Myeloid-Hem_Myeloid_macrophage-im_immature_macrophage2_(0)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.28e-06 | 190 | 89 | 6 | e0b363f772817cfc6ab425430805c1cddcba23f0 | |
| ToppCell | wk_15-18-Hematologic_Lymphocytic-T_&_ILC-Treg|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.28e-06 | 190 | 89 | 6 | fe6fecdf2123f3a4fb20e7535472d562b1a74fb4 | |
| ToppCell | Fetal_29-31_weeks-Immune-T_lymphocyte-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.35e-06 | 191 | 89 | 6 | 133864ec1e89f97a82c3bb01d2a3c658397fefaf | |
| ToppCell | (0)_T_CD4|World / Oesophagus cell shreds on cell class (v1) and cell subclass (v1) | 2.35e-06 | 191 | 89 | 6 | ba289658777a2669fda9da9128e87adb60fd8430 | |
| ToppCell | 5'-GW_trimst-2-LymphNode-Hematopoietic-T_cells-Treg|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.49e-06 | 193 | 89 | 6 | f3eb295a019de29f484964f00ea436860af249a5 | |
| ToppCell | 11.5-Airway-Immune-Hematopoietic,_T_Cells|Airway / Age, Tissue, Lineage and Cell class | 2.49e-06 | 193 | 89 | 6 | 7c14bc481ed38378b9e6a85f768a1e526c5997e6 | |
| ToppCell | PCW_10-12-Hematologic_Myeloid-Hem_Myeloid_monocytic-im_myeloid_progenitor2_(3)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.64e-06 | 195 | 89 | 6 | e8fb552f9ab77b656c27abc66af523b56cd9f9ad | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.64e-06 | 195 | 89 | 6 | ed5f772c82d4dfd1c8735224446ec9feae3fb8c2 | |
| ToppCell | (0)_NK/T_cells|World / Oesophagus cell shreds on cell class (v1) and cell subclass (v1) | 2.72e-06 | 196 | 89 | 6 | baee29014dc56c71a6ef790bb7ecd5b5271cfcb0 | |
| ToppCell | COVID_non-vent-Lymphocytic|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 2.81e-06 | 197 | 89 | 6 | c672915f8c8c1e948d251f6eaf9f84a5600c1193 | |
| ToppCell | T_cells-Treg_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 2.81e-06 | 197 | 89 | 6 | de5448fcdf4e433fc167496413abe5d0c8a5c6d8 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.89e-06 | 198 | 89 | 6 | 6d18b45eda4014759e6dd282d78ffd28df8a6044 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.89e-06 | 198 | 89 | 6 | 0ff30edfd3c133a42e8cb96e1631a1143215f808 | |
| ToppCell | Sepsis-Leuk-UTI-Lymphocyte-T/NK-Treg|Leuk-UTI / Disease, condition lineage and cell class | 2.97e-06 | 199 | 89 | 6 | 100f45e04f284551b29ef0406476bdc347ddbf7e | |
| ToppCell | 5'-GW_trimst-2-LymphNode-Hematopoietic|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.97e-06 | 199 | 89 | 6 | da20998253ad08a4a127a98b991b26237edb61a2 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-5w-Mesenchymal-Mesoderm|5w / Sample Type, Dataset, Time_group, and Cell type. | 3.06e-06 | 200 | 89 | 6 | 0927061536a664b4f7feb9e5b0a8c11ca0d5955c | |
| ToppCell | 367C-Lymphocytic-CD4_T-cell-Treg_cell_4|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.08e-05 | 145 | 89 | 5 | 29422c908d58081e6a748e362a7ac41bf001444c | |
| ToppCell | droplet-Lung-18m-Hematologic-lymphocytic-CD8-positive,_alpha-beta_T_cell-CD8-positive,_alpha-beta_T_cell_l21|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.24e-05 | 149 | 89 | 5 | 65778f19599b4955c0a16f0121237656449431fb | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-Treg_cell_4|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.32e-05 | 151 | 89 | 5 | 5d64655b6b09cc0a6d44629a31048b787a0916c5 | |
| ToppCell | Leuk-UTI-Lymphocyte-T_NK-Treg|Leuk-UTI / Disease, Lineage and Cell Type | 1.40e-05 | 153 | 89 | 5 | b24c693b142206d13b29c96faa7f79a1a22bc2ef | |
| ToppCell | Control-Lymphocyte-T_NK-Treg|Control / Disease, Lineage and Cell Type | 1.64e-05 | 158 | 89 | 5 | 260dc209f619e1d17a11cede979636001c749786 | |
| ToppCell | Healthy/Control-Treg|Healthy/Control / Disease group and Cell class | 1.69e-05 | 159 | 89 | 5 | 16a322760c99f3e2c3b73cbb399f77868951d3cb | |
| ToppCell | Healthy/Control-Treg|World / Disease group and Cell class | 1.80e-05 | 161 | 89 | 5 | 457297cda5c9cee3bcc069fdecbbe24def027e5f | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD4+_T-Treg-Treg_4|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.02e-05 | 165 | 89 | 5 | 4edc9714185a7519a7044487a3d6ea845131b851 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD4+_T-Treg-Treg_4|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.02e-05 | 165 | 89 | 5 | fd1d38b97564c1f64f5c7246dcec96d60364b7b2 | |
| ToppCell | droplet-Marrow-BM-30m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.08e-05 | 166 | 89 | 5 | 019d365df44c3bbd88c1f4bdceb3de0ff76d3e8d | |
| ToppCell | PND03-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD8_T-CD8_T_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.20e-05 | 168 | 89 | 5 | ade02beb8d663fce4be2aefa10392ab849a4bbe7 | |
| ToppCell | COVID-19_Moderate-Treg|World / disease group, cell group and cell class | 2.27e-05 | 169 | 89 | 5 | 27ad11239559b025bef582f89b2a83501d9d3993 | |
| ToppCell | droplet-Trachea-3m-Hematologic-myeloid-tracheal_macrophage-macrophage_of_tracheal_l15|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.40e-05 | 171 | 89 | 5 | 87cb65648c663e246f94cea1a5ed12e8e29ec629 | |
| ToppCell | droplet-Trachea-nan-3m-Myeloid-macrophage|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.47e-05 | 172 | 89 | 5 | f6c00a6a7e81aaf96c55eb3a3c88e3719f102ea0 | |
| ToppCell | droplet-Trachea-3m-Hematologic-myeloid-tracheal_macrophage|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.47e-05 | 172 | 89 | 5 | f3bbe3f069ad070778430d1a6cd9db0a76deb8de | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_T-T4_reg-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.47e-05 | 172 | 89 | 5 | 9497948bbe53fb88c6ff6b347f743d456da587e5 | |
| ToppCell | control-Lymphocytic-CD4_T_cells_3|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 2.54e-05 | 173 | 89 | 5 | 0c9fb18536ddd61b51b7bb4d40841f67b017f360 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Myeloid-Myeloid_Dendritic_Type_1|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.61e-05 | 174 | 89 | 5 | ff13a5c55d18b951315908f33cb47c7f9cb901bf | |
| ToppCell | LPS-IL1RA+antiTNF-Lymphocytic_NKT-T_cells-T-cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.75e-05 | 176 | 89 | 5 | 9d4a4dfeebb5a8a0f3ab18c37c8ddc2cd2158575 | |
| ToppCell | facs-GAT-Fat-3m-Lymphocytic-CD4-positive,_alpha-beta_T_cell|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.75e-05 | 176 | 89 | 5 | acd05ca8952710feedbfe377b1330f3c2406d044 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic-Classical_Dendritic_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.75e-05 | 176 | 89 | 5 | 5f8c1f917fba49f3b1c0d88b946eca242b668fde | |
| ToppCell | 10x3'2.3-week_14-16-Lymphocytic_T-T_NK-Treg|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.75e-05 | 176 | 89 | 5 | 2eb1827171e9c19f945e87824215721f8cf22258 | |
| ToppCell | LPS-IL1RA+antiTNF-Lymphocytic_NKT-T_cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.75e-05 | 176 | 89 | 5 | bb41e9478373726eb460af764de0277b2d09928e | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Hematopoietic-T_cells-ILC2|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.83e-05 | 177 | 89 | 5 | 9828504591599619649d41a78daf7c052729c669 | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_T-T4_reg-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.91e-05 | 178 | 89 | 5 | 90dedb3cef9b01907b9f8eec64218d6d2072be1f | |
| ToppCell | Control-Lymphocytic_NKT-T_cells-T-cells|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.91e-05 | 178 | 89 | 5 | 910f8bea19d335455aba24e6a07b4834b709db5d | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_T-T4_reg|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.91e-05 | 178 | 89 | 5 | d6312286bf6cc5b107ccd7adb583d9667d4e1d21 | |
| ToppCell | Control-Lymphocytic_NKT-T_cells|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.99e-05 | 179 | 89 | 5 | d892d9496f1c33e23312092591eb2e968e736f7d | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c12-FOXP3|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.07e-05 | 180 | 89 | 5 | 6bb9f41c3a99d1bbe697f589fb2bcea9b7bfbeee | |
| ToppCell | 367C-Lymphocytic-CD4_T-cell-CD4+_Naive_T_cell_/_CD4+_Trm_cell|367C / Donor, Lineage, Cell class and subclass (all cells) | 3.15e-05 | 181 | 89 | 5 | 9b155a74e68e485039a5195144a12833f2f75058 | |
| ToppCell | PCW_05-06-Immune_Lymphocytic|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 3.15e-05 | 181 | 89 | 5 | bd99c5849bb4979c891898312cb9f602c6831b23 | |
| ToppCell | systemic_lupus_erythematosus-flare-Hematopoietic-Progen-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 3.15e-05 | 181 | 89 | 5 | 55fcefa234c8fc707b23248e724756d69827cd18 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Hematopoietic-T_cells-SELL+_CD4_T|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.23e-05 | 182 | 89 | 5 | 7dd435e456da1470d19d3db307ae4909c25d2f0d | |
| ToppCell | wk_15-18-Hematologic_Lymphocytic-T_&_ILC-ILCP|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 3.23e-05 | 182 | 89 | 5 | 6bd48c5d60a259719f65cacee4b8135247e78fa9 | |
| ToppCell | B_cells-ABCs|B_cells / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 3.32e-05 | 183 | 89 | 5 | bf9c6fe3ce4e44e4056027257eab8448c39c4fb8 | |
| ToppCell | PCW_05-06-Immune_Lymphocytic-Immune_Lymphocytic_B|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 3.32e-05 | 183 | 89 | 5 | ffa7f2b2929ea4bd53f3f1ae23bd27f8bb4aac47 | |
| ToppCell | wk_08-11-Hematologic_Lymphocytic-T_&_ILC|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 3.40e-05 | 184 | 89 | 5 | 51ae0963b4fb034c3f605ee4e5da513cba7aca35 | |
| ToppCell | PCW_10-12-Immune_Lymphocytic-Immune_Lymphocytic_NK/ILC-im_ILC2_(21)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.40e-05 | 184 | 89 | 5 | 33db879e629821fb75684e60f8f0749cf9623bdd | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c12-FOXP3|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.40e-05 | 184 | 89 | 5 | 08bff25390e3484b75c860738396a405141b69fd | |
| ToppCell | Control-Lymphocytic_NKT|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.49e-05 | 185 | 89 | 5 | 59d68e119f58b35bab36294758f6b2e25fd8f5c0 | |
| ToppCell | COPD-Lymphoid-T_Regulatory|COPD / Disease state, Lineage and Cell class | 3.49e-05 | 185 | 89 | 5 | 846403edd4c8f646201d519055198fc38b7ffff9 | |
| ToppCell | -IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 3.49e-05 | 185 | 89 | 5 | 10f7e5daf8e95dda9453212e84b64874f4e0d7ab | |
| ToppCell | 343B-Lymphocytic-CD4_T-cell-Treg_cell_4|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 3.59e-05 | 186 | 89 | 5 | bca5215d406f1785bf3a420201d5686071fcaca5 | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_T_CD4-Tregs|bone_marrow / Manually curated celltypes from each tissue | 3.68e-05 | 187 | 89 | 5 | bda716a64262325e6e68b281caf131f1840fd298 | |
| ToppCell | systemic_lupus_erythematosus-flare-Hematopoietic-Progen|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 3.68e-05 | 187 | 89 | 5 | 16fffe894a2c7d5186556ad000e0be229511fbdb | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-Treg|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.77e-05 | 188 | 89 | 5 | 9db3d3010cb8a1f3ee1cdccaf3cbaac3cf983fc5 | |
| ToppCell | systemic_lupus_erythematosus-flare-Hematopoietic|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 3.77e-05 | 188 | 89 | 5 | 88b808561ebde997ac8a8bbd1d9bbda49bbb6646 | |
| ToppCell | LPS_only-Lymphocytic_NKT|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.77e-05 | 188 | 89 | 5 | bbe65b1c11c88ab62d8485cfc3a913ff9da89aad | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.77e-05 | 188 | 89 | 5 | 0d86044bc340e3efb90d0022dd299873639d831c | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-Treg|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.77e-05 | 188 | 89 | 5 | 72be6fe654f3a5f654d3b9680145bce7ae9b721d | |
| ToppCell | COVID-19_Mild-Lymphoid_T/NK-Treg|COVID-19_Mild / Disease group, lineage and cell class | 3.77e-05 | 188 | 89 | 5 | 42553fdc127e5f613ffd5067620a768a40f1a8a1 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_T-T4_reg|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 3.77e-05 | 188 | 89 | 5 | e5c480b9a030536578f1cc91fb61738f752525b3 | |
| ToppCell | (1)_T_CD4|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 3.87e-05 | 189 | 89 | 5 | 2298a96c53c5bd767e17554c50379b2d1ad8b5b0 | |
| ToppCell | (1)_T_cells|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 3.87e-05 | 189 | 89 | 5 | fa6b85676b2b61483ae27720d0715dbfcbcfbdf9 | |
| ToppCell | metastatic_Brain-T/NK_cells-CD4+_Th|metastatic_Brain / Location, Cell class and cell subclass | 3.87e-05 | 189 | 89 | 5 | a2b00fbe7b7b15db3fce88a56cbac0ef2917332c | |
| ToppCell | PCW_13-14-Immune_Lymphocytic-Immune_Lymphocytic_NK/ILC-im_ILC2_(21)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.87e-05 | 189 | 89 | 5 | 620d5a71b8cb6288540e2d2d848b9d4d66c1226f | |
| ToppCell | 10x5'v1-week_14-16-Lymphocytic_T-T_NK-Treg|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 3.97e-05 | 190 | 89 | 5 | 8540f4dee99280109e38b997d9247b176808c51a | |
| ToppCell | severe-Lymphocytic-CD4_T_cells_3|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 4.07e-05 | 191 | 89 | 5 | afff6bfae9a2f1e17d2731315e7fe63c4601679f | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_T-T4_reg-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 4.07e-05 | 191 | 89 | 5 | c5e22df4a8741b8096cdd1618271fd48d6265846 | |
| ToppCell | PCW_13-14-Hematologic_Myeloid-Hem_Myeloid_macrophage-im_immature_macrophage2_(0)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 4.07e-05 | 191 | 89 | 5 | 09dfad8e1fcaaf94775134796b99e4e3fbb9bf40 | |
| ToppCell | metastatic_Brain-T/NK_cells-Naive_CD4+_T|metastatic_Brain / Location, Cell class and cell subclass | 4.07e-05 | 191 | 89 | 5 | 4613eae77e2fbb1c526582de46ffed6bda61ea6b | |
| ToppCell | PCW_13-14-Hematologic_ErythroMegGranulo-Hem_Granulocytic-im_mast/basophil_(18)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 4.07e-05 | 191 | 89 | 5 | 14b11244c330cc4fe897253aaaf0df80caa01a55 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD4+_T-Treg|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.17e-05 | 192 | 89 | 5 | 7a90ec9fc8f29216c4828e0cf5d040906456e53b | |
| ToppCell | COVID-19_Severe-Lymphoid_T/NK-Treg|COVID-19_Severe / Disease group, lineage and cell class | 4.17e-05 | 192 | 89 | 5 | 3fb4c148dadcf5e79094e55c6bb53ec7bf9d44c8 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD4+_T-Treg|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.17e-05 | 192 | 89 | 5 | d883b91bbab71673de4858346d3ab33e5fbbf842 | |
| ToppCell | BAL-Severe-Lymphocyte-T/NK-CD4+_T-Treg-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.17e-05 | 192 | 89 | 5 | d85a785a12076e34c404171363a647f318926b18 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.17e-05 | 192 | 89 | 5 | 7ab626a516b07d899175ff12f1c8257688324e4b | |
| ToppCell | 18-Distal-Immune-Hematopoietic,_T_Cells|Distal / Age, Tissue, Lineage and Cell class | 4.17e-05 | 192 | 89 | 5 | 7538c7f63108f357478ea4c5bf27c1f9825b87c7 | |
| ToppCell | Healthy_Control-Lymphoid-T-CCR7+_T|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 4.17e-05 | 192 | 89 | 5 | 5b197f65a87c315e4f50c77a7fdec3b342a863ad | |
| ToppCell | Healthy-Treg|Healthy / disease group, cell group and cell class | 4.17e-05 | 192 | 89 | 5 | 9d3795a64bf0c62f460d80730c5615869fc46933 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-Tregs|lymph-node_spleen / Manually curated celltypes from each tissue | 4.17e-05 | 192 | 89 | 5 | 91a4d06e8d1d1fe2ce5f72668108513bd2a72c4d | |
| ToppCell | BAL-Severe-Lymphocyte-T/NK-CD4+_T-Treg|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.17e-05 | 192 | 89 | 5 | 230f3090607a62bb6d1e1f4b0341ee96d93f1c00 | |
| ToppCell | wk_20-22-Hematologic_Lymphocytic-T_&_ILC-Treg|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 4.17e-05 | 192 | 89 | 5 | 0deb6aa323e1de72ee8a2002449e523dd4f0bf5d | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-Z|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.17e-05 | 192 | 89 | 5 | 8dc3016601148243196e925641c9507e9d58c9e0 | |
| Drug | Sulfamethazine sodium salt [1981-58-4]; Up 200; 13.4uM; MCF7; HT_HG-U133A | 8.12e-07 | 197 | 86 | 8 | 3940_UP | |
| Drug | Metronidazole [443-48-1]; Up 200; 23.4uM; MCF7; HT_HG-U133A | 9.21e-06 | 195 | 86 | 7 | 4141_UP | |
| Drug | Dihydroergocristine mesylate [24730-10-7]; Up 200; 5.6uM; MCF7; HT_HG-U133A | 9.21e-06 | 195 | 86 | 7 | 2895_UP | |
| Drug | Ethionamide [536-33-4]; Up 200; 24uM; PC3; HT_HG-U133A | 9.21e-06 | 195 | 86 | 7 | 4593_UP | |
| Drug | Meclofenoxate hydrochloride [3685-84-5]; Up 200; 13.6uM; MCF7; HT_HG-U133A | 1.02e-05 | 198 | 86 | 7 | 3405_UP | |
| Disease | pulmonary fibrosis (biomarker_via_orthology) | 1.46e-05 | 50 | 87 | 4 | DOID:3770 (biomarker_via_orthology) | |
| Disease | Early Pregnancy Loss | 1.82e-05 | 109 | 87 | 5 | C3830362 | |
| Disease | Spontaneous abortion | 1.82e-05 | 109 | 87 | 5 | C0000786 | |
| Disease | Miscarriage | 1.82e-05 | 109 | 87 | 5 | C4552766 | |
| Disease | Abortion, Tubal | 1.82e-05 | 109 | 87 | 5 | C0000822 | |
| Disease | mucinous adenocarcinoma (is_marker_for) | 8.54e-05 | 5 | 87 | 2 | DOID:3030 (is_marker_for) | |
| Disease | carbamazepine metabolite measurement | 1.28e-04 | 6 | 87 | 2 | EFO_0009891 | |
| Disease | glypican-1 measurement | 1.79e-04 | 7 | 87 | 2 | EFO_0801649 | |
| Disease | unipolar depression, anorexia nervosa | 3.81e-04 | 10 | 87 | 2 | EFO_0003761, MONDO_0005351 | |
| Disease | Liver Cirrhosis, Experimental | 4.64e-04 | 774 | 87 | 9 | C0023893 | |
| Disease | Acute myeloid leukemia | 1.14e-03 | 17 | 87 | 2 | cv:C0023467 | |
| Disease | LEUKEMIA, ACUTE MYELOID | 1.14e-03 | 17 | 87 | 2 | 601626 | |
| Disease | unipolar depression, bipolar disorder | 1.19e-03 | 156 | 87 | 4 | EFO_0003761, MONDO_0004985 | |
| Disease | prostate carcinoma | 1.25e-03 | 891 | 87 | 9 | EFO_0001663 | |
| Disease | Epilepsy, Cryptogenic | 1.85e-03 | 82 | 87 | 3 | C0086237 | |
| Disease | Awakening Epilepsy | 1.85e-03 | 82 | 87 | 3 | C0751111 | |
| Disease | Aura | 1.85e-03 | 82 | 87 | 3 | C0236018 | |
| Disease | post-traumatic stress disorder symptom measurement | 1.85e-03 | 82 | 87 | 3 | EFO_0008535 | |
| Disease | Nasopharyngeal carcinoma | 1.91e-03 | 22 | 87 | 2 | C2931822 | |
| Disease | Eczema | 2.27e-03 | 310 | 87 | 5 | HP_0000964 | |
| Disease | traumatic brain injury (biomarker_via_orthology) | 2.27e-03 | 24 | 87 | 2 | DOID:0081292 (biomarker_via_orthology) | |
| Disease | West Syndrome | 2.27e-03 | 24 | 87 | 2 | C0037769 | |
| Disease | paracentral lobule volume measurement | 2.47e-03 | 25 | 87 | 2 | EFO_0010317 | |
| Disease | Heart valve disease | 2.67e-03 | 26 | 87 | 2 | C0018824 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| MHRLQLSDTGTYTCQ | 101 | P09564 | |
| RSHRQMSCVNKESQY | 701 | Q9NP73 | |
| HEEMQRIIQHCSNYS | 436 | O00429 | |
| YSDLQRSSSEQAMRC | 196 | P32248 | |
| NQDFSALMRSSYHCA | 151 | Q13489 | |
| SYHCAMNNENARLLT | 161 | Q13489 | |
| RLETEMQSYHCRLNA | 1596 | A6QL64 | |
| ASSRHCTYLENGMQD | 1266 | Q8N2N9 | |
| RRCTIMGSEYSHQEN | 446 | O94823 | |
| SCVKINSHNYRNEEM | 101 | P57052 | |
| MSQTQDYECRSHNVD | 1 | Q9C0H5 | |
| TDHMEHNNLCTLYQR | 726 | O95980 | |
| DLLNCYQMETVRSDN | 476 | O60674 | |
| TMQNLNDRLASYLDH | 86 | Q7Z3Y9 | |
| TCYMELQVLDLHNNS | 86 | Q6ZSA7 | |
| RQYQICLAIDDSSSM | 5381 | Q9NU22 | |
| QLYSTILSHQCQRME | 106 | Q9Y4H4 | |
| SYQQLHTLSDMDLNN | 481 | Q6NUN7 | |
| HCTNVMAQSVQASRY | 86 | P0DKB6 | |
| QLVQHEILCSMTNSY | 176 | Q86Z02 | |
| NISYITALNMCHQFS | 1981 | Q8IYD8 | |
| CMYAILQNNHTLFTD | 526 | Q9Y233 | |
| HLSSLQDYMQRCTNE | 211 | O60437 | |
| YHFESNQRTCNMTVL | 56 | P56589 | |
| DMLLNVDQCSTHLNY | 1276 | Q9ULK4 | |
| SDCSYIDPMTHNLNR | 231 | Q9NX36 | |
| QMNSLRAEDTALYHC | 101 | A0A0C4DH32 | |
| SMYSLEGNTVEHRCQ | 5566 | P98088 | |
| MSQQDFCASNRLNHY | 161 | Q8NGE2 | |
| ERCHNYLQNVSMEAA | 216 | Q9UKS7 | |
| LCNSRQLYDHMIDDS | 476 | Q14520 | |
| AYHNSVECLQMLINA | 51 | Q9Y575 | |
| LLHSMACNQSAVYLQ | 1511 | Q96N67 | |
| QHITLLMCSAYRNQL | 471 | O15228 | |
| AASDLMSYCEQHARN | 31 | O60262 | |
| MKNHRESNSNQCVYA | 526 | P43004 | |
| CMRNAFHENDTIYSL | 231 | Q5TCH4 | |
| ATYINHNFSQQCLRM | 316 | O15371 | |
| QLCQAHSQLLQYMER | 416 | A8MPP1 | |
| NSMSLRDEHNYTLSI | 201 | O15033 | |
| ACDLTYEHQRNMDSK | 736 | Q9P2S6 | |
| DHIRQMAYQICQSIN | 261 | Q9HAZ1 | |
| LESTMNEYHRRLNCN | 721 | Q16478 | |
| RCNMLSHSLTTYQRT | 216 | Q8NDH6 | |
| VHQIQYREMNSCLNA | 1091 | Q86VB7 | |
| NQRSMFDHLSYLLEN | 2246 | P21817 | |
| EKELRTECNHYNNIM | 896 | Q16531 | |
| LNDVRQSANYTCVAM | 291 | P23468 | |
| ASRCNLLSHMLATYQ | 221 | Q05084 | |
| CSEHLQSLYSRTMEA | 551 | Q6ZUA9 | |
| SVENCMCVLHNLSYR | 471 | Q13835 | |
| SRCVNDMHNFTNEIL | 326 | O95197 | |
| ETHYENYRAQCIQSM | 401 | O43236 | |
| CSTAQRMYQSLEHEL | 4021 | Q8NF91 | |
| QHLCQYTQLRHETDM | 421 | O60861 | |
| ERLNRMYNCTTTHTL | 251 | Q16819 | |
| LQMYNSQHRSAISCI | 171 | Q9NYZ2 | |
| HNANLEYSANCLRMV | 256 | Q8TBK2 | |
| NSQSQAKTYTMERCH | 386 | O00444 | |
| SLNEMRCAYEVTQAN | 546 | P61764 | |
| MQTDTQDHQKLCYSA | 491 | Q9NZQ3 | |
| TEIQRLTYSQEMCDN | 1046 | Q9Y2K9 | |
| LESSSLCDYRNDMNA | 466 | P51790 | |
| ITRQQYQNALTACHM | 781 | Q9NRU3 | |
| RLMSTEASQNITYHC | 1356 | P02452 | |
| ENSMSISILLDNYCH | 511 | P48736 | |
| HLDYLIQCTNEMNVN | 41 | Q13492 | |
| LCNRNNMTTHVSFRS | 456 | Q15111 | |
| QCLDHAQQNLYRDVM | 31 | P0CB33 | |
| HENQRLCKSTDYMNL | 1646 | Q8NB66 | |
| MTQADLYRVNNSNCL | 136 | Q99973 | |
| SDRYTNLEEHCQRMT | 131 | Q9NXB0 | |
| DQKLYMSCIAHSRDQ | 211 | Q8N1Q8 | |
| MSCIAHSRDQQTVYA | 216 | Q8N1Q8 | |
| QNLTREQADYCVSHM | 2431 | Q13813 | |
| QCLDHAQQNLYRDVM | 31 | Q8IYX0 | |
| MDCYLTHTNDTAFLQ | 231 | O43280 | |
| TCYMNSILQVLSHLQ | 261 | Q70CQ1 | |
| QCLDHAQQNLYRDVM | 31 | A6NP11 | |
| NYGRLCHAQSRSMND | 266 | Q9BY07 | |
| SDSAQTEACYHMLSR | 186 | Q86UX7 | |
| QATNETQMCYASLDH | 101 | Q6PIZ9 | |
| ARHVCLNQSIDTYTM | 406 | Q8N680 | |
| CRRQQHMQSTFDNTI | 211 | Q3SY77 | |
| SCQRQQQLMDQAHIY | 41 | A6NGA9 | |
| RMQDYQDSCILHSLS | 206 | P40818 | |
| MEAYRTQNCFLNSEI | 461 | Q9BYX2 | |
| CNVAYSQSSTLEIHM | 1601 | Q15911 | |
| NNLDNVCMHLTNYAI | 281 | A6NNM8 | |
| NVYITRAQLMNCHVS | 376 | Q96RE7 | |
| DNCSLMYLNEATLLH | 61 | Q9UM54 |